1. Occurrence of Existing BCR-ABL Baseline Mutations and Associated Haplotype (NmR) Among CML Patients with Diverse IM Response: A Hospital-based Study from North-East India
   Gautam Hazarika et al, 2024, Biochemical Genetics CrossRef
2. High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective
   Mukul Arvind Gharote, 2024, International Journal of Molecular and Immuno Oncology CrossRef
3. Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase
   Shyam A. Patel et al, 2021, JCO Precision Oncology CrossRef
4. Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes
   Nobuko Hijiya et al, 2023, Cancer Management and Research CrossRef
5. A review of the therapeutic role of the new third-generation TKI olverembatinib in chronic myeloid leukemia
   Honglan Qian et al, 2022, Frontiers in Oncology CrossRef
6. The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients
   Hyunkyung Park et al, 2022, Leukemia Research CrossRef
7. Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study
   Zahidah Abu Seman et al, 2024, BMC Research Notes CrossRef
8. Utility of T315I mutation in Egyptian patients with chronic myeloid leukemia
   Alyaa Mohamed Ghoneem et al, 2024, Egyptian Journal of Basic and Applied Sciences CrossRef
9. Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
   Amir Imran Faisal Hamdi et al, 2022, Expert Review of Anticancer Therapy CrossRef
10. Genetic alterations in the BCR-ABL1 fusion gene related to imatinib resistance in chronic myeloid leukemia
    Macario Martínez-Castillo et al, 2023, Leukemia Research CrossRef
11. The Impact of SKP2 Gene Expression in Chronic Myeloid Leukemia
    Hossam Hodeib et al, 2022, Genes CrossRef
12. Molecular BCR::ABL1 Quantification and ABL1 Mutation Detection as Essential Tools for the Clinical Management of Chronic Myeloid Leukemia Patients: Results from a Brazilian Single-Center Study
    Anelis Maria Marin et al, 2023, International Journal of Molecular Sciences CrossRef
13. Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
    Arti Easwar et al, 2021, Life CrossRef
14. FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial
    E Dianne Pulte et al, 2022, The Oncologist CrossRef